Evidence map›Paper›PMID 39712399›Full record

ReviewEpilepsy currents2024

Epilepsy Therapies Symposium | Do We Really "Outgrow" Seizures?

Adam Ostendorf, Genna J Waldman, Lara Jehi, Mohammed Ilyas, Dean Naritoku, Alica M Goldman

Abstract readReview
In one paragraph

Review in Epilepsy currents, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam OstendorfNationwide Children's Hospital, Ohio State University, Columbus, OH, USA.
Genna J WaldmanDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Lara JehiCleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-8041-6377
Mohammed IlyasChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Dean NaritokuDepartment of Neurology, University of South Alabama, AL, USA.
Alica M GoldmanDepartment of Neurology, Baylor College of Medicine, Houston, TX, USA.ORCID https://orcid.org/0000-0002-5491-5746

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initiation and maintenance of antiseizure therapy can be relatively straightforward in most patients. Depending on epilepsy type, patients may be more or less likely to enter remission or a resolution of their epilepsy and the International League Against Epilepsy developed clinically guiding definitions in this regard. The mechanisms by which resolution or remission are achieved are poorly understood which complicates clinical decision making and risk estimate for future seizure relapse. The impetus for the maintenance of medical therapy in a seizure-free patient is also age-dependent. In children, one ought to consider the unknown effects of antiseizure medications on the developing brain while family planning, lifestyle, education, or employment are some of the issues that affect the decision making in adults. Patients who enter remission following surgical remediation of their epilepsy represent a distinct category and medication discontinuation is influenced by a number of factors. Another important consideration is comorbidities that often affect medication choices and maintenance. When formulating a management strategy, patient preferences together with careful evaluation and precise and accurate epilepsy diagnosis are key towards guiding medical or surgical management, prognostication for seizure freedom, relapse risk, options for medication discontinuation, and understanding risks and types of comorbidities.

Indexed as

comorbidityepilepsyremissionsurgerytherapy

Identifiers

PMID39712399
PMCPMC11660101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.